Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the guidance by NICE entitled Covid-19 rapid guideline: managing symptoms (including at the end of life) in the community, NG163, published on 3 April 2020, which medical experts were consulted during the commissioning process.

The National Institute for Health and Care Excellence (NICE) guideline NG163, published in 2020, was commissioned in accordance with an established agreement between NHS England and NICE. The focus at that time was given to providing rapid guidance on the management of affected patients with COVID-19. The following organisations were consulted on the guideline:

- Association for Palliative Medicine;

- Palliative Care Formulary;

- Wolfson Palliative Care Research Centre;

- Cicely Saunders Institute;

- NHS England;

- ICU Steps;

- Macmillan Cancer Support;

- Marie Curie;

- National Audit for Care at the End of Life;

- Palliative Care for Wales;

- Royal College of General Practitioners;

- Royal College of Physicians; and

- Sue Ryder.

The following organisations provided general practice consultation on the guidance:

- NICE GP Reference Group; and

- RCGP Network.

A number of NICE’s COVID-19 rapid guidelines were subsequently incorporated into a single guideline, NG191, for the management of COVID-19 in children and adults. The list of panel members for this guideline is available at the following link:

https://www.nice.org.uk/guidance/ng191/documents/register-of-interests-2